Phillips 66/ US7185461040 /
2024-04-25 10:10:00 PM | Chg. -0.55 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
157.24USD | -0.35% | 2.62 mill. Turnover: 289.43 mill. |
156.24Bid Size: 100 | 158.00Ask Size: 400 | 67.27 bill.USD | 2.67% | 10.11 |
GlobeNewswire
04-25
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
GlobeNewswire
04-19
Latest Research Reveals What’s Really Keeping Consumers From Eating Fruits and Vegetables
GlobeNewswire
04-19
Adams Natural Resources Fund Declares Distribution and Announces First Quarter Performance
GlobeNewswire
04-16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
04-11
2024 IBWSS Communication Awards Honor Leaders in Boating and Water Safety Outreach
GlobeNewswire
04-11
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Offi...
GlobeNewswire
04-10
NSBC Recognizes the Marine Sports Foundation with the 2024 Silver Schooner Award
GlobeNewswire
04-04
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a ...
GlobeNewswire
04-03
45Drives Joins Ceph Foundation at Diamond Level, Elevating Open-Source Collaboration
GlobeNewswire
04-03
Advanced Glazings and WinTech Partner on New Products to Create Sustainable Novel Features and Human...
GlobeNewswire
03-28
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treat...
GlobeNewswire
03-27
Phillips Edison & Company Inc. Invites You to Join Its First Quarter 2024 Earnings Conference Call
GlobeNewswire
03-18
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
03-13
James Satterwhite, CEO of Advanced Glazings, Ltd., to Speak at BuildGreen Atlantic 2024 Conference